Benjamin L. Morris

426 total citations
8 papers, 194 citations indexed

About

Benjamin L. Morris is a scholar working on Molecular Biology, Genetics and Cognitive Neuroscience. According to data from OpenAlex, Benjamin L. Morris has authored 8 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Genetics and 1 paper in Cognitive Neuroscience. Recurrent topics in Benjamin L. Morris's work include Kruppel-like factors research (5 papers), Cancer-related gene regulation (4 papers) and Genetic Syndromes and Imprinting (2 papers). Benjamin L. Morris is often cited by papers focused on Kruppel-like factors research (5 papers), Cancer-related gene regulation (4 papers) and Genetic Syndromes and Imprinting (2 papers). Benjamin L. Morris collaborates with scholars based in United States, France and Japan. Benjamin L. Morris's co-authors include Steven R. Grossman, Keith C. Ellis, M. Michael Dcona, Robert M. Freeman, Johannes C. Walter, Tatsuro Takahashi, Courtney G. Havens, William E. Royer, Brendan J. Hilbert and Aziza Lebbar and has published in prestigious journals such as Journal of Biological Chemistry, Molecular Pharmacology and Bioorganic & Medicinal Chemistry.

In The Last Decade

Benjamin L. Morris

7 papers receiving 192 citations

Peers

Countries citing papers authored by Benjamin L. Morris

Since Specialization

Citations

This map shows the geographic impact of Benjamin L. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin L. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin L. Morris more than expected).

Fields of papers citing papers by Benjamin L. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin L. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin L. Morris. The network helps show where Benjamin L. Morris may publish in the future.

Co-authorship network of co-authors of Benjamin L. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin L. Morris. A scholar is included among the top collaborators of Benjamin L. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin L. Morris. Benjamin L. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Cancer Therapies Targeting Cellular Metabolism 2024 ·Cold Spring Harbor Perspectives in Medicine ·Benjamin L. Morris, Alejandro Gutiérrez	0
2	Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities 2019 ·Molecular Pharmacology ·M. Michael Dcona, Priyadarshan K. Damle, (unknown), Benjamin L. Morris, (unknown), Michael J. Dennis, Xiaoyan Deng, (unknown), (unknown), Keith C. Ellis, William E. Royer, Dipankar Bandyopadhyay, Carlos Escalante, Steven R. Grossman	10
3	CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors 2017 ·Cancer Biology & Therapy ·M. Michael Dcona, Benjamin L. Morris, Keith C. Ellis, Steven R. Grossman	66
4	Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP) 2016 ·Bioorganic & Medicinal Chemistry ·(unknown), Benjamin L. Morris, Hardik I. Parikh, (unknown), (unknown), Ian M. Love, Brendan J. Hilbert, William E. Royer, Glen E. Kellogg, Steven R. Grossman, Keith C. Ellis	21
5	Understanding and targeting the C-terminal Binding Protein (CtBP) substrate-binding domain for cancer therapeutic development 2016 ·VCU Scholars Compass (Virginia Commonwealth University) ·Benjamin L. Morris	2
6	Structure-Guided Design of a High Affinity Inhibitor to Human CtBP 2015 ·ACS Chemical Biology ·Brendan J. Hilbert, Benjamin L. Morris, Keith C. Ellis, Janet L. Paulsen, Celia A. Schiffer, Steven R. Grossman, William E. Royer	21
7	Thymine DNA Glycosylase Is a CRL4Cdt2 Substrate 2014 ·Journal of Biological Chemistry ·(unknown), Benjamin L. Morris, Courtney G. Havens, Robert M. Freeman, Tatsuro Takahashi, Johannes C. Walter	41
8	Dose dependent expression of HDAC4 causes variable expressivity in a novel inherited case of brachydactyly mental retardation syndrome 2012 ·American Journal of Medical Genetics Part A ·Benjamin L. Morris, (unknown), Sylvie Bourthoumieu, (unknown), Cécile Laroche, Aziza Lebbar, Catherine Yardin, Sarah H. Elsea	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact